1. Home
  2. LYRA vs SOS Comparison

LYRA vs SOS Comparison

Compare LYRA & SOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • SOS
  • Stock Information
  • Founded
  • LYRA 2005
  • SOS 2004
  • Country
  • LYRA United States
  • SOS China
  • Employees
  • LYRA N/A
  • SOS N/A
  • Industry
  • LYRA Medical/Dental Instruments
  • SOS Finance: Consumer Services
  • Sector
  • LYRA Health Care
  • SOS Finance
  • Exchange
  • LYRA Nasdaq
  • SOS Nasdaq
  • Market Cap
  • LYRA 15.0M
  • SOS 17.0M
  • IPO Year
  • LYRA 2020
  • SOS 2017
  • Fundamental
  • Price
  • LYRA $7.95
  • SOS $7.03
  • Analyst Decision
  • LYRA Buy
  • SOS
  • Analyst Count
  • LYRA 2
  • SOS 0
  • Target Price
  • LYRA $16.00
  • SOS N/A
  • AVG Volume (30 Days)
  • LYRA 91.5K
  • SOS 95.4K
  • Earning Date
  • LYRA 08-13-2025
  • SOS 09-23-2025
  • Dividend Yield
  • LYRA N/A
  • SOS N/A
  • EPS Growth
  • LYRA N/A
  • SOS N/A
  • EPS
  • LYRA N/A
  • SOS N/A
  • Revenue
  • LYRA $1,185,000.00
  • SOS $231,424,000.00
  • Revenue This Year
  • LYRA N/A
  • SOS N/A
  • Revenue Next Year
  • LYRA $139.18
  • SOS N/A
  • P/E Ratio
  • LYRA N/A
  • SOS N/A
  • Revenue Growth
  • LYRA N/A
  • SOS 150.42
  • 52 Week Low
  • LYRA $3.81
  • SOS $4.04
  • 52 Week High
  • LYRA $37.50
  • SOS $15.51
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 41.08
  • SOS 49.11
  • Support Level
  • LYRA $7.77
  • SOS $6.77
  • Resistance Level
  • LYRA $8.67
  • SOS $8.92
  • Average True Range (ATR)
  • LYRA 0.45
  • SOS 1.00
  • MACD
  • LYRA -0.03
  • SOS -0.10
  • Stochastic Oscillator
  • LYRA 11.32
  • SOS 11.37

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About SOS SOS Limited

SOS Ltd is a multifaceted company that leverages the power of data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other services. The company has three reporting segments: Commodity trading, Cryptocurrency mining, and Others. Key revenue is generated from Commodity trading.

Share on Social Networks: